Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Appl Psychophysiol Biofeedback. 2008 Mar;33(1):1-28. doi: 10.1007/s10484-007-9047-5. Epub 2008 Jan 24.

EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research.

Author information

  • 1Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, USA. tato.sokhadze@louisville.edu

Abstract

Electroencephalographic (EEG) biofeedback has been employed in substance use disorder (SUD) over the last three decades. The SUD is a complex series of disorders with frequent comorbidities and EEG abnormalities of several types. EEG biofeedback has been employed in conjunction with other therapies and may be useful in enhancing certain outcomes of therapy. Based on published clinical studies and employing efficacy criteria adapted by the Association for Applied Psychophysiology and Biofeedback and the International Society for Neurofeedback and Research, alpha theta training-either alone for alcoholism or in combination with beta training for stimulant and mixed substance abuse and combined with residential treatment programs, is probably efficacious. Considerations of further research design taking these factors into account are discussed and descriptions of contemporary research are given.

PMID:
18214670
[PubMed - indexed for MEDLINE]
PMCID:
PMC2259255
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk